128 related articles for article (PubMed ID: 32509985)
1. CYP2C19 polymorphisms and outcomes of Escitalopram treatment in Brazilians with major depression.
Bernini de Brito R; Ghedini PC
Heliyon; 2020 May; 6(5):e04015. PubMed ID: 32509985
[TBL] [Abstract][Full Text] [Related]
2. Influence of
Islam F; Magarbeh L; Elsheikh SSM; Kloiber S; Espinola CW; Bhat V; Frey BN; Milev R; Soares CN; Parikh SV; Placenza F; Hassel S; Taylor VH; Leri F; Blier P; Uher R; Farzan F; Lam RW; Turecki G; Foster JA; Rotzinger S; Kennedy SH; Müller DJ
Can J Psychiatry; 2024 Mar; 69(3):183-195. PubMed ID: 37796764
[TBL] [Abstract][Full Text] [Related]
3. Impact of cytochrome P450 2C19 polymorphisms on citalopram/escitalopram exposure: a systematic review and meta-analysis.
Chang M; Tybring G; Dahl ML; Lindh JD
Clin Pharmacokinet; 2014 Sep; 53(9):801-11. PubMed ID: 25154506
[TBL] [Abstract][Full Text] [Related]
4. Effect of cytochrome CYP2C19 metabolizing activity on antidepressant response and side effects: Meta-analysis of data from genome-wide association studies.
Fabbri C; Tansey KE; Perlis RH; Hauser J; Henigsberg N; Maier W; Mors O; Placentino A; Rietschel M; Souery D; Breen G; Curtis C; Lee SH; Newhouse S; Patel H; O'Donovan M; Lewis G; Jenkins G; Weinshilboum RM; Farmer A; Aitchison KJ; Craig I; McGuffin P; Schruers K; Biernacka JM; Uher R; Lewis CM
Eur Neuropsychopharmacol; 2018 Aug; 28(8):945-954. PubMed ID: 30135031
[TBL] [Abstract][Full Text] [Related]
5. Effects of CYP2C19 and CYP2D6 gene variants on escitalopram and aripiprazole treatment outcome and serum levels: results from the CAN-BIND 1 study.
Islam F; Marshe VS; Magarbeh L; Frey BN; Milev RV; Soares CN; Parikh SV; Placenza F; Strother SC; Hassel S; Taylor VH; Leri F; Blier P; Uher R; Farzan F; Lam RW; Turecki G; Foster JA; Rotzinger S; Kennedy SH; Müller DJ
Transl Psychiatry; 2022 Sep; 12(1):366. PubMed ID: 36068210
[TBL] [Abstract][Full Text] [Related]
6. Genotype-phenotype analysis of CYP2C19 in healthy saudi individuals and its potential clinical implication in drug therapy.
Saeed LH; Mayet AY
Int J Med Sci; 2013; 10(11):1497-502. PubMed ID: 24046523
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms of cytochrome P450 enzymes influence metabolism of the antidepressant escitalopram and treatment response.
Tsai MH; Lin KM; Hsiao MC; Shen WW; Lu ML; Tang HS; Fang CK; Wu CS; Lu SC; Liu SC; Chen CY; Liu YL
Pharmacogenomics; 2010 Apr; 11(4):537-46. PubMed ID: 20350136
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the INNOVANCE PFA P2Y assay and its association with CYP2C19 genotypes.
Kim H; Kim Y; Koh YS; Lee HK; Chae H; Jekarl DW; Lee JM; Shin WS; Kim TH
Platelets; 2015; 26(2):148-53. PubMed ID: 24617511
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome P450 2C19 Poor Metabolizer Phenotype in Treatment Resistant Depression: Treatment and Diagnostic Implications.
Veldic M; Ahmed AT; Blacker CJ; Geske JR; Biernacka JM; Borreggine KL; Moore KM; Prieto ML; Vande Voort JL; Croarkin PE; Hoberg AA; Kung S; Alarcon RD; Keeth N; Singh B; Bobo WV; Frye MA
Front Pharmacol; 2019; 10():83. PubMed ID: 30837869
[No Abstract] [Full Text] [Related]
10. Effect of CYP2C19 polymorphisms on antidepressant prescription patterns and treatment emergent mania in bipolar disorder.
Joas E; Jonsson L; Viktorin A; Smedler E; Pålsson E; Goodwin GM; Landén M
Pharmacogenomics J; 2023 Jan; 23(1):28-35. PubMed ID: 36333412
[TBL] [Abstract][Full Text] [Related]
11. Effects of Cytochrome P450 (CYP) 2C19 Genotypes on Steady-State Plasma Concentrations of Escitalopram and its Desmethyl Metabolite in Japanese Patients With Depression.
Tsuchimine S; Ochi S; Tajiri M; Suzuki Y; Sugawara N; Inoue Y; Yasui-Furukori N
Ther Drug Monit; 2018 Jun; 40(3):356-361. PubMed ID: 29570504
[TBL] [Abstract][Full Text] [Related]
12. CYP2C19 loss-of-function is associated with increased risk of hypertension in a Hakka population: a case-control study.
Cai N; Li C; Gu X; Zeng W; Zhong J; Liu J; Zeng G; Zhu J; Hong H
BMC Cardiovasc Disord; 2023 Apr; 23(1):185. PubMed ID: 37024851
[TBL] [Abstract][Full Text] [Related]
13. CYP2C19 variation, not citalopram dose nor serum level, is associated with QTc prolongation.
Kumar Y; Kung S; Shinozaki G
J Psychopharmacol; 2014 Dec; 28(12):1143-8. PubMed ID: 25122046
[TBL] [Abstract][Full Text] [Related]
14. Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population.
Scordo MG; Caputi AP; D'Arrigo C; Fava G; Spina E
Pharmacol Res; 2004 Aug; 50(2):195-200. PubMed ID: 15177309
[TBL] [Abstract][Full Text] [Related]
15. Combined effect of CYP2C19 and CYP2D6 genotypes on escitalopram serum concentration and its metabolic ratio in a European patient population.
Faraj P; Haslemo T; Tran JP; Stingl J; Molden E; Hole K
Br J Clin Pharmacol; 2024 Jun; ():. PubMed ID: 38925553
[TBL] [Abstract][Full Text] [Related]
16. Concentrations of escitalopram in blood of patients treated in a naturalistic setting: focus on patients with alcohol and benzodiazepine use disorder.
Hart XM; Heesen S; Schmitz CN; Dörfler S; Wedekind D; Gründer G; Hiemke C; Havemann-Reinecke U
Eur Arch Psychiatry Clin Neurosci; 2023 Feb; 273(1):75-83. PubMed ID: 36207527
[TBL] [Abstract][Full Text] [Related]
17. CYP2C19 Genotyping May Provide a Better Treatment Strategy when Administering Escitalopram in Chinese Population.
Huang X; Li C; Li C; Li Z; Li X; Liao J; Rao T; Chen L; Gao L; Ouyang D
Front Pharmacol; 2021; 12():730461. PubMed ID: 34512354
[TBL] [Abstract][Full Text] [Related]
18. [Clinical efficacy and achievement of a complete remission in depression: increasing interest in treatment with escitalopram].
Favré P
Encephale; 2012 Feb; 38(1):86-96. PubMed ID: 22381728
[TBL] [Abstract][Full Text] [Related]
19. Effects of CYP2C19 allelic variants on inhibition of platelet aggregation and major adverse cardiovascular events in Japanese patients with acute coronary syndrome: The PRASFIT-ACS study.
Ogawa H; Isshiki T; Kimura T; Yokoi H; Nanto S; Takayama M; Kitagawa K; Nishikawa M; Miyazaki S; Ikeda Y; Nakamura M; Tanaka Y; Saito S
J Cardiol; 2016 Jul; 68(1):29-36. PubMed ID: 26521100
[TBL] [Abstract][Full Text] [Related]
20. The Effects of CYP2C19 Genotype on Proxies of SSRI Antidepressant Response in the UK Biobank.
Wong WLE; Fabbri C; Laplace B; Li D; van Westrhenen R; Lewis CM; Dawe GS; Young AH
Pharmaceuticals (Basel); 2023 Sep; 16(9):. PubMed ID: 37765085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
